ANNEX 1: Professional Profile

Dr. Stergiopoulos is a strong executive leader in Research & Development in the field of non-invasive medical diagnostic vital signs monitoring and imaging technologies. He has established an excellent track record in pursuing innovations from inception to successful completion that have formed the basis of viable Medical Technology R&D Infrastructures at the Canadian Defence Lab, DRDC Toronto and in the private sector (i.e. CANAMET www.canamet.com). His track record includes:

• preparation of proposals with success in receiving significant grant support (total $11 million),

• leadership in coordinating large scale international collaborative projects supported by the European Commission EC-IST funding program and with project consortiums including the known Industrial and Academic European Institutes, Fraunhofer, Philips, Siemens (Germany), ESAOTE (Italy), ATMEL (Italy), NTUA (Greece), QinetiQ (UK), DDRE (Denmark), TNO (Netherlands), and the Canadian Institutes: University of Toronto, the Univ. of Western Ontario (Lawson & Robarts Imaging Labs), CANAMET and IMRIS.

• establishing collaborative arrangements for the clinical testing and assessment of project results with the following Medical Research Centers:

  • the Lawson Health Research Institute of the University of Western Ontario, London ON

  • Walter Reed Medical Research Center of the US Army, Washington DC, USA

  • US Army Aeromedical Research Centre, Fort Rucker, AL, USA,

• documentation and patent protection of Intellectual Property (IP) rights of innovations,

• successful completion of technology developments reaching the preliminary stage of products ready for regulatory approvals (i.e. FDA, CSA, CE), and transfer of their IP rights to medical manufacturing companies for commercialization,

• generation of royalties for his former employer (DRDC Toronto that holds ownership of the licensed IP rights.